Table 3.
Age-Standardized Prevalence Rates (Percent) of Dyslipidemia and Treatment stratified by Cardiovascular Disease (CHD, stroke, PVD)
| Outcomes | Non-Hispanic Whites | Asian Indians | Chinese | Filipinos | Japanese | Koreans | Vietnamese | Mexicans | Black/ Africans |
|---|---|---|---|---|---|---|---|---|---|
| History of Cardiovascular Disease (N=8,016) | |||||||||
| Women | |||||||||
| High LDL-C Ever | 83.6 (81.1, 86.0) | 85.0 (73.3, 96.8) | 79.6 (71.7, 87.4) | 92.7 (84.2, 100.0) | 81.0 (68.0, 94.0) | 98.2 (93.0, 100.0) | 88.0 (--, --) | 86.3 (76.1, 96.6) | 84.2 (73.6, 94.8) |
| Low HDL-C ever | 44.2 (40.6, 47.7) | 60.8 (43.4, 78.3) | 47.9 (37.6, 58.2) | 44.6 (28.4, 60.8) | 49.0 (31.2, 66.8) | 44.6 (0.0, 92.4) | 70.2 (34.1, 100.0) | 64.6 (48.7, 80.5) | 47.3 (31.7, 62.9) |
| High TG Ever | 46.5 (42.9, 50.0) | 51.9 (34.0, 69.9) | 48.8 (38.4, 59.2) | 55.2 (38.8, 71.6) | 68.3 (51.6, 84.9) | 62.4 (14.6, 100.0) | 58.6 (10.7, 100.0) | 63.8 (47.8, 79.9) | 28.9 (14.5, 43.3) |
| Ever Treated by LLAs | 64.9 (61.9, 67.8) | 73.2 (59.1, 87.4) | 62.8 (53.7, 71.9) | 83.8 (71.4, 96.2) | 70.6 (55.6, 85.7) | 87.4 (68.2, 100.0) | 76.4 (50.1,100.0) | 72.8 (59.4, 86.2) | 71.5 (58.0, 84.9) |
| Men | |||||||||
| High LDL-C Ever | 90.3 (88.6, 92.0) | 94.8 (90.4, 99.1) | 87.9 (82.6, 93.3) | 96.8 (92.5, 100.0) | 96.1 (89.0, 100.0) | 98.6 (95.8, 100.0) | 95.5 (85.2, 100.0) | 89.4 (79.6,99.2) | 89.7 (80.6,98.8) |
| Low HDL-C ever | 48.4 (45.3, 51.4) | 56.7 (46.6, 66.7) | 42.5 (34.0, 51.1) | 46.8 (30.8, 62.9) | 40.0 (21.4, 58.5) | 41.1 (16.7, 65.5) | 46.5 (20.1,72.9) | 61.1 (45.3, 76.9) | 49.0 (28.1, 69.9) |
| High TG Ever | 49.6 (46.6, 52.6) | 53.3 (43.3, 63.4) | 52.9 (44.4, 61.4) | 65.9 (50.5, 81.3) | 58.7 (40.8,76.7) | 76.9 (57.0, 96.7) | 45.0 (19.5,70.5) | 58.6 (42.8, 74.5) | 33.0 (12.7, 53.3) |
| Ever Treated by LLAs | 79.4 (77.1, 81.7) | 89.3 (83.3, 95.2) | 80.7 (74.3, 87.1) | 93.8 (87.8, 99.8) | 89.2 (77.5,100.0) | 97.6 (94.2, 100.0) | 79.8 (60.6, 99.0) | 78.3 (65.9, 90.8) | 82.6 (71.7, 93.6) |
|
| |||||||||
| No History of Cardiovascular Disease (N=161,414) | |||||||||
| Women | |||||||||
| High LDL-C Ever | 50.9 (50.1,51.6) | 53.1 (50.2, 56.0) | 44.2 (42.6, 45.8) | 61.4 (58.5, 64.2) | 52.7 (48.9, 56.5) | 49.5 (43.0,55.9) | 54.7 (49.5,60.0) | 54.8 (51.3, 58.3) | 54.9 (50.3, 59.5) |
| Low HDL-C ever | 30.0 (29.2,30.8) | 54.5 (51.3, 57.7) | 31.1 (29.5, 32.7) | 36.8 (33.7, 40.0) | 22.7 (19.2, 26.1) | 33.8 (26.9,40.7) | 36.3 (30.9,41.7) | 49.8 (46.1,53.6) | 38.6 (33.9,43.3) |
| High TG Ever | 26.6 (25.9,27.3) | 36.6 (33.5, 39.7) | 29.0 (27.5, 30.6) | 40.7 (37.6, 43.9) | 34.6 (30.7, 38.4) | 28.3 (21.8,34.8) | 37.9 (32.5,43.2) | 44.3 (40.7, 48.0) | 17.5 (13.8, 21.2) |
| Ever Treated by LLAs | 16.5 (16.0, 17.0) | 18.4 (16.2, 20.6) | 13.4 (12.4, 14.5) | 27.9 (25.4, 30.3) | 17.4 (14.9, 19.9) | 15.4 (10.8, 20.1) | 18.7 (14.5, 22.9) | 22.0 (19.2, 24.8) | 21.6 (18.1, 25.0) |
| Men | |||||||||
| High LDL-C Ever | 59.9 (59.1, 60.7) | 63.0 (60.7, 65.3) | 53.4 (51.6, 55.2) | 71.0 (67.5, 74.6) | 63.4 (58.4, 68.4) | 52.8 (44.6, 61.0) | 69.4 (64.2, 74.7) | 63.8 (59.7, 67.8) | 61.0 (55.8, 66.2) |
| Low HDL-C ever | 34.7 (33.9, 35.5) | 52.1 (49.6, 54.6) | 33.7 (32.0, 35.4) | 36.2 (32.3, 40.1) | 25.6 (21.0, 30.2) | 28.1 (20.9, 35.2) | 32.7 (27.3, 38.2) | 46.9 (42.6, 51.3) | 33.0 (28.0, 38.1) |
| High TG Ever | 42.0 (41.1, 42.8) | 55.3 (52.8, 57.8) | 48.6 (46.8, 50.4) | 59.8 (55.9, 63.7) | 52.3 (47.0, 57.5) | 52.3 (44.1,60.6) | 56.7 (51.0, 62.4) | 56.0 (51.7, 60.3) | 29.2 (24.3, 34.1) |
| Ever Treated by LLAs | 22.6 (22.0, 23.2) | 28.4 (26.3, 30.4) | 18.5 (17.2, 19.8) | 34.7 (31.3, 38.1) | 24.8 (20.9, 28.7) | 19.6 (13.3, 25.9) | 27.0 (22.2,31.7) | 27.0 (23.5, 30.4) | 27.3 (23.0, 31.5) |
Data are percent with 99% CI; --small sample size
CHD = Coronary Heart Disease, PVD = Peripheral Vascular Disease, HDL-C = high density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; TG= triglycerides; LLAs=LDL-lowering agents.